Materials and Methods
This prospective cohort study was carried out in the Department of Obstetrics and Gynecology, Maternal -Fetal Medicine Unit, School of Medicine, Izmir Katip Celebi University, Izmir, Turkey and the Department of Obstetrics and Gynecology, Maternal -Fetal Medicine Unit, Sanliurfa Education and Research Hospital, Sanliurfa, Turkey between January 2012 and May 2018. Both hospitals are referral centers. Approval for this study was obtained by the Department of Obstetrics and Gynecology Clinical Academic Board. The study design was in accordance with the Declaration of Helsinki for medical research involving human subjects and conformed to the Committee on Publication Ethics Guidelines.
A total of 1168 diagnostic prenatal invasive procedures on singleton pregnancies were performed. Out of this, 1052 singleton pregnant women who had undergone diagnostic prenatal invasive procedures were included in the study and 116 patients who had induced abortion after the procedures were excluded. Other exclusion criteria were the following: multiple pregnancies planned cervical cerclage, uterine mullerian anomalies, and the absence of perinatal outcome information.
Positive screening in the first and second trimester screening tests was described in the case of a higher risk than the cut-off with 5% false positive rate. Appropriate diagnostic prenatal invasive procedures were performed according to the various gestational ages.
Transvaginal sonographic CL measurement was performed on all the patients, right after the invasive procedures. Transvaginal CL measurements were provided by Voluson E6 and Voluson E8 (General Electric, Milwaukee, WI, USA) devices according to Fetal Medicine Foundation (FMF) Guidelines [11] in a dorsal lithotomy position. All ultrasound examinations were carried out by only two maternal-fetal medicine specialists (SK ORIGINAL 2 of 4 and EE), both with Fetal Medicine Foundation Certificate accreditation for competence in cervical assessment. A sagittal view of the cervix was obtained without applying cervical pressure with the ultrasound probe, and then the calipers were used to measure the linear distance between the triangular area of echodensity at the external os and the V-shaped notch at the internal os. When the cervix was curved, two or more segments were measured. The shortest cervical length was recorded. Miscarriages occurred within two weeks after the procedures were evaluated as procedure-related. All patients who have undergone diagnostic invasive procedures were followed up for procedure-related loss for two weeks.
For all cases, the procedure-related characteristics (indication, technique, the diameter of the needle, and the number of needle entries), as well as maternal characteristics (maternal age, gestational age during the procedure, CL), obstetric history, pregnancy outcome, and fetal karyotype results were recorded (Table 1 and 2).
The main outcome measure was the procedure-related loss in accordance with the first and mid-trimester CL. The demographic data of patients with ongoing pregnancies and miscarriages were compared with the patients with all other variables.
Statistical analyses were performed using MedCalc Statistical Software (MedCalc Software, Ostend, Belgium). Statistical data was reported descriptively due to a small number of miscarriages. Categorical variables were given as median (minimum-maximum). P < 0.05 was considered statistically significant.
Results
Baseline maternal and pregnancy characteristics of the study population are shown in Table 1 . The mean gestational age of 1052 singleton pregnancies at the procedure was 17 ± 2.2 weeks (11-32). Median gravida was 2 (1-9) and parity was 1 (0-7) ( Table 1) . Amniocentesis was performed on 883 patients (83.9%) after 16 weeks gestation, CVS was carried out transabdominally on 93 patients (8.84%) between 11-14 weeks, and cordocentesis was performed on 76 patients (7.2%) ( Table 2) .
Fetal karyotypes were normal on 971 pregnancies (92.3%) and were abnormal on 81 patients (7.7%). Mean CL was 32 ± 4.6 mm (18-51 mm). We had a total of two miscarriages. One of them was at the 13th week of pregnancy that had undergone CVS at the 12th week of pregnancy due to increased nuchal translucency and the other one was at the18th week of pregnancy that has undergone amniocentesis due to the positive screening on second trimester screening test at the 16th week of pregnancy. AS, Amniocentesis; CS, Cordocentesis; CVS, Chorionic villus sampling; SD, standard deviation.
Karyotypes were normal in both miscarriages. CL of the CVS patient was 28 mm and that of the amniocentesis patient was 30 mm. Procedure-related rate was 0.19%. Mean CL was 29 mm in the miscarriage group and 32.7 ± 4.7 mm in the ongoing pregnancy group (Table 2) .
No significant difference was found between the pregnancies concluded with miscarriage and the ongoing pregnancies, with respect to the following variables: the size of the needle, needle insertion location, test indication, number of insertions, and karyotyping results.
Discussion
In this prospective multicenter study, CL was taken during 11-24 weeks gestations. The small number of patients complicated with miscarriage was not enough to make a statistical analysis and to validate the conclusion. In general, however, the miscarriage rate after diagnostic invasive procedures was very low. Therefore, it was difficult to perform a random-ORIGINAL ized clinical trial with a large sample size. But, our results demonstrated that CL was within normal limits in the patients complicated with miscarriage after diagnostic invasive procedures. We did not detect any association between procedure-related miscarriage and CL.
The bulk of evidence from randomized trials suggests that the rate of spontaneous loss attributed to the amniocentesis procedure ranges from 0.06 to 1.0 percent [2, 12, 13] . The data for CVS are equally inconsistent, partly because of different methods used to obtain chorionic villi (transabdominal compared with transvaginal). Transabdominal CVS and amniocentesis appear to be associated with similar rates of miscarriage. Miscarriage rate within 14 days of transabdominal CVS was 0.7 percent, and 0.6 percent for amniocentesis, while it was almost twofold higher (1.4 to 1.9 percent) for cordocentesis than in controls [2, 4, 14] . In our study population, procedure-related miscarriage rates were similar to these results for transabdominal CVS and amniocentesis, as 1.07% and 0.11%, respectively. Some of the factors that may influence the miscarriage risk after procedures are multiple needle insertions, needle size, indication of procedure, and the technical skills of the operator. Presence of fetal anomalies as an indication for diagnostic amniocentesis is associated with increased risk of fetal loss (odds ratio: 8.5) [6] . In this study population, we had only two miscarriages and karyotypes of them were normal.
Repeated attempts during the procedure also proved risk factors for miscarriage [6, 13] . Although it is unlikely that needle size is a significant factor, a study reporting the highest miscarriage rate used a 19 G needle, while another study reporting a significantly lower miscarriage rate with 0.2% used 21 G [15, 16] . Based on the data for multiple insertions, it may be appropriate to use a benchmark, as 2% of amniocentesis procedures and 5.5% of transabdominal CVS procedures [2] . In our study, more than one needle puncture was required only in 3% of all patients. 21 G needle was used for amniocentesis and cordocentesis. 18 G needle was used for chorionic villous sampling. All procedures were done by experienced maternal-fetal medicine specialists.
Recent studies have suggested that the first trimester CL screening with maternal characteristics could be feasible for prediction of early spontaneous preterm birth with 54.8% detection rate. Studies focusing on the length of endocervical canal have reported that median CL is between 31-34 mm during 11-13 weeks that varies with maternal characteristics such as height and race [17, 18] . Although the pathophysiology of spontaneous preterm birth is multifactorial, the CL evaluation in the second trimester has been shown to be one of the best predictors in low-risk population with the risk of preterm birth being inversely associated with that [8, 19] . In a recent prospective cohort study, significantly increased risk of preterm delivery is reported in case of short CL in low risk population [20] . Also, it has been shown that a low-risk population corresponds to low proportions of women with a short cervix in the second trimester [20] . In our study, CLs were 28 and 30 mm, respectively, in the first and second trimesters in procedure related miscarriages, and the Mean CL was 32.7 mm in ongoing pregnancies. We could not conclude statistically evidenced result with this data, but the cervical length was within normal limits at both miscarriages.
A possible limitation to our study was that the transvaginal CL measurement was performed right after all prenatal invasive procedures. Possible uterine contractions depending on the procedure could affect the cervix measurement. But, we recorded the shortest CL during measurements to prevent this. An important strength of the study is the prospective design with high intra-and inter-observer reliability for CL measurement [21] . Additionally, this is the first study evaluating the efficacy of CL on the prediction of miscarriage attributed to the prenatal invasive procedures.
Conclusion
In this prospective clinical trial, despite the small study population, we can make a conclusion that CL screening at the first trimester and at the second trimester may show poor performance for prediction of procedural dependent miscarriage. That's why CL evaluation may not be a prognostic factor for miscarriage due to all types of prenatal invasive procedures.
